Interleukin 6 receptor is associated with adverse postoperative clinical outcomes of patients with l

来源 :第十二届国际胃癌学术会议 | 被引量 : 0次 | 上传用户:keyina
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Background: Imatinib(Marketed as Glivec in USA and Gleevec in Europe)is a tyrosine kinase inhibitor(TKI),commonly used as a first-line therapy for treatment of Gastrointestinal Stromal Tumors(GIST)and
Background: TNM stage is based on the survival data of gastric cancer patients who underwent radical gastrectomy without neoadjuvant therapy.Whether it is fit for the patients after neoadjuvant chemot
会议